Search for Companies, Tipsters or Sources…
Companies
Tipsters
Brokers
Sources
Or view the latest share tips
Company Results
Tipster results
Broker results
Sources results
Fund Manager results
Tips from these results
Recent Share tips:
- Avoid URU Metals Ltd. (DI) (URU) by Nigel Somerville in ShareProphets
- Sell Videndum (VID) by Steve Moore in ShareProphets
- Avoid PZ Cussons (PZC) by Steve Moore in ShareProphets
- Avoid TT Electronics (TTG) by Steve Moore in ShareProphets
- Sell Microsaic Systems (MSYS) by Steve Moore in ShareProphets
- Sell The Revel Collective (TRC) by Steve Moore in ShareProphets
- Buy KEFI Gold and Copper (KEFI) by Hot Stock Rockets in ShareProphets
- Avoid Naked Wines (WINE) by Steve Moore in ShareProphets
- Sell Mirriad Advertising (MIRI) by Steve Moore in ShareProphets
- Hold M&G (MNG) by Cliff D'Arcy in The Motley Fool
- Buy Safestore Holdings (SAFE) by Zaven Boyrazian in The Motley Fool
- Buy Altona Rare Earths (REE) by Hot Stock Rockets in ShareProphets
- Avoid Surgical Innovations Group (SUN) by Steve Moore in ShareProphets
- Outperform OSB Group (OSB) by RBC Capital
- Buy Diageo (DGE) by Harvey Jones in The Motley Fool
- Watch Nexteq (NXQ) by Steve Moore in ShareProphets
- Overweight Jet2 (JET2) by Barclays
- Outperform IntegraFin Holding (IHP) by RBC Capital
- Outperform Volution Group (FAN) by RBC Capital
- Sector Perform Currys (CURY) by RBC Capital
GSK (GSK) Share Price
Health Care Sector
NOTE: This is based on 1,421 open tips for GSK (GSK)
| Latest Bid : 1,799.50p | Latest Ask : 1,800.50p |
| High Today : 1,806.00p | Low Today : 1,793.00p |
| This Years High : 1,833.50p | This Years Low : 1,264.00p |
| Volume : 757,136 | MKT Cap : £74630.73M |
| Trading Velocity : Premium Only | Activity Score : Premium Only |
| Consensus Score : Premium Only | Momentum Score : Premium Only |
GSK (GSK) Overview
We are a global biopharma company with a purpose to unite science, technology and talent to get ahead of disease together. We aim to positively impact the health of 2.5 billion people by the end of 2030. Our bold ambitions for patients are reflected in commitments to growth and a step-change in performance. We are a company where outstanding people can thrive.GSK (GSK) Latest Tips
| Type | Tipster | SectorScore | Start date | Performance |
|---|---|---|---|---|
| Underweight | JP Morgan | Premium Only | 2025-12-08 04:50:00 08/12/2025 | 0.66% |
| Hold | Berenberg | Premium Only | 2025-11-25 05:38:00 25/11/2025 | 0.56% |
| Buy | Simon Watkins | Premium Only | 2025-11-10 10:00:00 10/11/2025 | 1.15% |
| Underweight | JP Morgan | Premium Only | 2025-11-07 04:48:00 07/11/2025 | -0.39% |
| Hold | Deutsche Bank | Premium Only | 2025-11-04 07:06:00 04/11/2025 | 1.95% |
GSK (GSK) Active Short Positions
| Fund Manager | Position | Date | ||
|---|---|---|---|---|
| No active short positions | ||||
| Latest Bid : 1,799.50p | Latest Ask : 1,800.50p |
| High Today : 1,806.00p | Low Today : 1,793.00p |
| This Years High : 1,833.50p | This Years Low : 1,264.00p |
| Volume : 757,136 | MKT Cap : £74630.73M |
GSK Overview
We are a global biopharma company with a purpose to unite science, technology and talent to get ahead of disease together. We aim to positively impact the health of 2.5 billion people by the end of 2030. Our bold ambitions for patients are reflected in commitments to growth and a step-change in performance. We are a company where outstanding people can thrive.NOTE: This description is in part generated by ChatGPT and not an endorsement by or the opinion of Stockomendation Ltd.
Latest GSK Tips
| Type | Tipster | SectorScore | Start date | Performance |
|---|---|---|---|---|
| Underweight | JP Morgan | Premium Only | 2025-12-08 04:50:00 08/12/2025 | 0.66% |
| Hold | Berenberg | Premium Only | 2025-11-25 05:38:00 25/11/2025 | 0.56% |
| Buy | Simon Watkins | Premium Only | 2025-11-10 10:00:00 10/11/2025 | 1.15% |
| Underweight | JP Morgan | Premium Only | 2025-11-07 04:48:00 07/11/2025 | -0.39% |
| Hold | Deutsche Bank | Premium Only | 2025-11-04 07:06:00 04/11/2025 | 1.95% |